Skip to content

Effect of Shenfu Decoction on the prognosis of patients with septic cardiomyopathy of Ji Xing Xu Zheng

Effect of Shenfu Decoction on the prognosis of patients with septic cardiomyopathy of Ji Xing Xu Zheng

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006556
Enrollment
Unknown
Registered
2022-09-02
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic cardiomyopathy

Interventions

Control group:Nasal feeding with normal saline
Treatment group:Nasal Feeding with Shenfu Decoction

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Patients over 18 years old; 2) Patients with confirmed or suspected infection; 3) SOFA score = 2 points; 4) Cardiac ultrasound prompts new cardiac dysfunction; 5) Informed consent signed by the subjects themselves or their legal representatives.

Exclusion criteria

Exclusion criteria: 1) Patients with previous cardiac insufficiency; 2) Patients with previous chronic kidney disease; 3) Patients with previous hepatic insufficiency: liver function (ALT, AST) = 2 times the upper limit of normal; 4) Pregnancy or perinatal patients; 5) Patients who are allergic to ginseng ingredients; 6) Patients who are known to have participated in any other clinical trials within 3 months.

Design outcomes

Primary

MeasureTime frame
28-day mortality;

Countries

China

Contacts

Public ContactTao LI
littlestudy@126.com18911939446

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026